These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 18059582

  • 21. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.
    Aasen G, Fagertun H, Halse J.
    Scand J Clin Lab Invest; 2008; 68(3):204-11. PubMed ID: 18446527
    [Abstract] [Full Text] [Related]

  • 22. Surrogate indexes vs. euglycaemic-hyperinsulinemic clamp as an indicator of insulin resistance and cardiovascular risk factors in overweight and obese postmenopausal women.
    Malita FM, Karelis AD, St-Pierre DH, Garrel D, Bastard JP, Tardif A, Prud'homme D, Rabasa-Lhoret R.
    Diabetes Metab; 2006 Jun; 32(3):251-5. PubMed ID: 16799402
    [Abstract] [Full Text] [Related]

  • 23. Psychosocial correlates of cardiorespiratory fitness and muscle strength in overweight and obese post-menopausal women: a MONET study.
    Karelis AD, Fontaine J, Messier V, Messier L, Blanchard C, Rabasa-Lhoret R, Strychar I.
    J Sports Sci; 2008 Jul; 26(9):935-40. PubMed ID: 18569559
    [Abstract] [Full Text] [Related]

  • 24. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?
    Brochu M, Tchernof A, Turner AN, Ades PA, Poehlman ET.
    Metabolism; 2003 May; 52(5):599-604. PubMed ID: 12759890
    [Abstract] [Full Text] [Related]

  • 25. Changes in glucose disposal after a caloric restriction-induced weight loss program in obese postmenopausal women: characteristics of positive and negative responders in a Montreal-Ottawa New Emerging Team study.
    Myette-Côté É, Doucet É, Prud'homme D, Rabasa-Lhoret R, Lavoie JM, Brochu M.
    Menopause; 2015 Jan; 22(1):96-103. PubMed ID: 24977460
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of insulin sensitivity with a new lipid-based index in non-diabetic postmenopausal overweight and obese women before and after a weight loss intervention.
    Antuna-Puente B, Disse E, Faraj M, Lavoie ME, Laville M, Rabasa-Lhoret R, Bastard JP.
    Eur J Endocrinol; 2009 Jul; 161(1):51-6. PubMed ID: 19429699
    [Abstract] [Full Text] [Related]

  • 27. Fasting triglyceride is a major determinant of postprandial triglyceride response in postmenopausal women.
    Hwu CM, Lin MW, Liou TL, Hsiao LC, Liang KW, Tsai TT, Ho LT.
    Menopause; 2008 Jul; 15(1):150-6. PubMed ID: 17549035
    [Abstract] [Full Text] [Related]

  • 28. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
    Sanip Z, Ariffin FD, Al-Tahami BA, Sulaiman WA, Rasool AH.
    Obes Res Clin Pract; 2013 Jul; 7(4):e315-20. PubMed ID: 24306161
    [Abstract] [Full Text] [Related]

  • 29. Variation in C-reactive protein following weight loss in obese insulin resistant postmenopausal women: is there an independent contribution of lean body mass?
    Barsalani R, Riesco É, Perreault K, Imbeault P, Brochu M, Dionne IJ.
    Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):198-203. PubMed ID: 25658658
    [Abstract] [Full Text] [Related]

  • 30. Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women.
    Park JS, Nam JS, Cho MH, Yoo JS, Ahn CW, Jee SH, Lee HS, Cha BS, Kim KR, Lee HC.
    Menopause; 2010 Jul; 17(4):779-84. PubMed ID: 20215975
    [Abstract] [Full Text] [Related]

  • 31. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI, Scott RS, Lewis JG, Elder PA, Frampton CM.
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [Abstract] [Full Text] [Related]

  • 32. Degradation in insulin sensitivity with increasing severity of the metabolic syndrome in obese postmenopausal women.
    Karelis AD, Henry JF, St-Pierre DH, Prud'homme D, Rabasa-Lhoret R.
    Diabetes Obes Metab; 2006 May; 8(3):336-41. PubMed ID: 16634994
    [Abstract] [Full Text] [Related]

  • 33. Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: a MONET (Montreal Ottawa New Emerging Team) study.
    Strychar I, Lavoie ME, Messier L, Karelis AD, Doucet E, Prud'homme D, Fontaine J, Rabasa-Lhoret R.
    J Am Diet Assoc; 2009 Apr; 109(4):718-24. PubMed ID: 19328269
    [Abstract] [Full Text] [Related]

  • 34. Weight loss reduces C-reactive protein levels in obese postmenopausal women.
    Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET.
    Circulation; 2002 Feb 05; 105(5):564-9. PubMed ID: 11827920
    [Abstract] [Full Text] [Related]

  • 35. Similar associations of total adiponectin and high molecular weight adiponectin with cardio-metabolic risk factors in a population of overweight and obese postmenopausal women: a MONET study.
    Elisha B, Ziai S, Karelis AD, Rakel A, Coderre L, Imbeault P, Rabasa-Lhoret R.
    Horm Metab Res; 2010 Jul 05; 42(8):590-4. PubMed ID: 20486084
    [Abstract] [Full Text] [Related]

  • 36. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women.
    Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT.
    Obes Res; 2002 Dec 05; 10(12):1203-6. PubMed ID: 12490663
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of TG-HDL Ratio Instead of HOMA Ratio as Insulin Resistance Marker in Overweight and Children with Obesity.
    Behiry EG, El Nady NM, AbdEl Haie OM, Mattar MK, Magdy A.
    Endocr Metab Immune Disord Drug Targets; 2019 Dec 05; 19(5):676-682. PubMed ID: 30663576
    [Abstract] [Full Text] [Related]

  • 38. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes.
    Moro E, Gallina P, Pais M, Cazzolato G, Alessandrini P, Bittolo-Bon G.
    Metabolism; 2003 May 05; 52(5):616-9. PubMed ID: 12759893
    [Abstract] [Full Text] [Related]

  • 39. Synergistic associations of physical activity and diet quality on cardiometabolic risk factors in overweight and obese postmenopausal women.
    Lavoie ME, Faraj M, Strychar I, Doucet É, Brochu M, Lavoie JM, Rabasa-Lhoret R.
    Br J Nutr; 2013 Feb 28; 109(4):605-14. PubMed ID: 22571776
    [Abstract] [Full Text] [Related]

  • 40. Use of markers of dyslipidemia to identify overweight youth with insulin resistance.
    Hannon TS, Bacha F, Lee SJ, Janosky J, Arslanian SA.
    Pediatr Diabetes; 2006 Oct 28; 7(5):260-6. PubMed ID: 17054447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.